share_log

Assessing AbbVie: Insights From 17 Financial Analysts

Benzinga ·  03:00

AbbVie (NYSE:ABBV) underwent analysis by 17 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings58400
Last 30D10000
1M Ago01100
2M Ago15000
3M Ago32300

Analysts have set 12-month price targets for AbbVie, revealing an average target of $211.24, a high estimate of $231.00, and a low estimate of $191.00. This current average has increased by 0.55% from the previous average price target of $210.08.

bigjpg

Diving into Analyst Ratings: An In-Depth Exploration

The standing of AbbVie...

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment